NCT07325136
Clinical Trial Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07325136
Title A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
lung small cell carcinoma
Therapies
BMS-986525
BMS-986525 + BNT327
Age Groups: adult | senior
Covered Countries USA | ROU | ITA | ESP

Facility Status City State Zip Country Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Local Institution - 0026 NOT_YET_RECRUITING Buffalo New York 14263 United States Details
Duke Cancer Institute RECRUITING Durham North Carolina 27710 United States Details
University Hospitals Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Local Institution - 0029 NOT_YET_RECRUITING Beijing Beijing Municipality 100036 China Details
Local Institution - 0028 NOT_YET_RECRUITING Shanghai Shi Shanghai Municipality 200120 China Details
Istituto Clinico Humanitas RECRUITING Rozzano Milano 20089 Italy Details
Local Institution - 0020 NOT_YET_RECRUITING Hirakata Osaka 573-1191 Japan Details
Local Institution - 0018 NOT_YET_RECRUITING Chuo-ku Tokyo 104-0045 Japan Details
Oncohelp Medical Center RECRUITING Timișoara Timiș County 300239 Romania Details
Centrul de Oncologie Sf. Nectarie SRL RECRUITING Craiova 200347 Romania Details
Hospital Universitario 12 de Octubre RECRUITING Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field